Glucophage

Glucophage is the brand name for the oral medication metformin hydrochloride, a biguanide antidiabetic drug commonly supplied in tablet form. It is approved in the European Union for the management of elevated blood glucose in adults with type 2 diabetes mellitus. The product works by decreasing hepatic glucose production, reducing intestinal glucose absorption, and improving peripheral insulin sensitivity, thereby supporting glycemic control as part of a comprehensive treatment plan.

Glucophage is indicated for the treatment of type 2 diabetes mellitus and is used as part of a comprehensive glycemic management strategy.

- Improves blood glucose control when used with diet and exercise in adults with type 2 diabetes. - Can be combined with other oral antidiabetic agents or insulin to achieve target HbA1c levels. - May be prescribed for patients with obesity‑related insulin resistance as an adjunct to lifestyle modification. - Used off‑label in some regions for polycystic ovary syndrome to improve metabolic parameters. - Recommended for long‑term maintenance therapy to prevent disease progression and complications.

Common and serious adverse reactions have been reported with metformin therapy; most are mild and reversible, while a few require immediate medical attention.

Common: - Nausea, vomiting, or abdominal discomfort, especially during treatment initiation. - Diarrhea or loose stools that usually improve with dose adjustment. - Metallic taste in the mouth that may lessen over time. - Decreased appetite or mild weight loss.

Serious: - Lactic acidosis, a rare but life‑threatening condition marked by rapid breathing and muscle pain. - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before starting Glucophage, clinicians should evaluate patient history and laboratory values to minimize risks and ensure safe use.

- Assess renal function; avoid use in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²). - Monitor liver enzymes; discontinue if hepatic disease is present or develops. - Check for contraindications such as acute or chronic metabolic acidosis. - Use caution in elderly patients due to higher risk of gastrointestinal side effects. - Advise patients to report unexplained fatigue, muscle pain, or rapid breathing promptly.

Metformin may interact with several medications; some combinations should be avoided, while others require dose adjustments or close monitoring.

Avoid: - Iodinated contrast agents used for imaging studies, which can precipitate acute kidney injury. - Cimetidine, as it may increase metformin plasma concentrations. - Certain antiretroviral drugs (e.g., didanosine) that raise the risk of lactic acidosis.

Use with caution: - Diuretics and ACE inhibitors, which can affect renal function and metformin clearance. - Beta‑blockers, because they may mask hypoglycemia symptoms. - Thyroid hormones, as altered metabolism may influence glucose control.